Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.)
Profile
Mailing Address: 999 West Broadway
Suite 720
Vancouver, British Columbia
V5Z 1K5
Head Office Address: 9920 Pacific Heights Blvd.
Suite 150
San Diego, California
92121
Contact Name: Scott Praill Principal Regulator: British Columbia
Business e-mail address: spraill@kintara.com Short Form Prospectus Issuer: Yes
Telephone Number: 604 202-1384 Reporting Jurisdictions: British Columbia, Other than Canada
Fax Number: 604 738-4080 Stock Exchange: NASDAQ
Date of Formation: Jun 24 2009 Stock Symbol: KTRA
Jurisdiction Where Formed: Nevada Auditor: Marcum LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 49720K Transfer Agent: Mountain Share Transfer, LLC
Financial Year-End: Jun 30 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents